Navigation Links
GranuFlo Recall Lawyers at Wright & Schulte LLC Investigating GranuFlo Lawsuits on Behalf of Dialysis Patients Allegedly Injured by GanuFlo or NaturaLyte
Date:8/12/2013

Columbus, OH (PRWEB) August 13, 2013

The GranuFlo recall lawyers at Wright & Schulte LLC, an experienced law firm representing the victims of defective drugs, are now evaluating GranuFlo lawsuits relating to the March 2012 GranuFlo and Naturalyte dialysis concentrate recall. GranuFlo and NaturaLyte, both manufactured and marketed by Fresenius Medical Care, were named in a Class I recall by the U.S. Food & Drug Administration (FDA). A Class I recall is the FDA’s most serious recall and is issued when a medical product poses a risk of serious injury or death.
[fda.gov/MedicalDevices/Safety/ListofRecalls/ucm309990.htm, FDA, March 29, 2013]

Dialysis patients or their surviving family members may be eligible to file a GranuFlo lawsuit if they suffered a sudden, serious heart problem during or after a dialysis treatment that involved the administration of GranuFlo or NaturaLyte, including:

  • Heart Attack
  • Stroke
  • Cardiopulmonary Arrest
  • Dangerously Low Blood Pressure
  • Sudden Cardiac Death

Wright & Schulte LLC is offering free GranuFlo lawsuit legal consultations to individuals who may be eligible to file a GranuFlo recall claim. For more information on filing a GranuFlo lawsuit, or to arrange for a free GranuFlo lawsuit legal consultation, please visit yourlegalhelp.com.

GranuFlo and NaturaLyte are administered during dialysis to neutralize acid in the blood. According to an Urgent Product Notification issued by Fresenius Medical Care in March 2012, both drugs have the potential to cause high levels of bicarbonate in the blood, which can cause dialysis patients to experience metabolic alkalosis. Metabolic alkalosis is associated with the occurrence of sudden, serious heart problems, which can ultimately lead to death. Because of the severity of GranuFlo side effects, the FDA designated the notification a Class I recall.
[fda.gov/MedicalDevices/Safety/ListofRecalls/ucm309990.htm, FDA, March 29, 2013]

Court filings show that more than 300 GranuFlo lawsuits have been filed in a federal multidistrict litigation that has been established in U.S. District Court, District of Massachusetts for federal personal injury claims stemming from the GranuFlo and NaturaLyte recall. The litigation’s Initial Scheduling Conference will be held on August 30, 2013. Plaintiffs in these GranuFlo lawsuits allege that Fresenius Medical Care was aware of the heart problems associated with the drugs, but concealed those risks from doctors and patients, and continued to aggressively market GranuFlo and NaturaLyte in spite of that knowledge. According to court documents, Fresenius sent a memo to its own dialysis centers in November 2011 warning that GranuFlo had been associated with an increase in incidents of cardiac arrest at Fresenius dialysis clinics in 2010. Doctors were advised to take steps to avoid elevated bicarbonate levels in patients, including adjusting dosage of the drug. However, clinics outside of the Fresenius network were not issued a similar warning until Fresenius announced its Urgent Product Notification March 2012. [In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428]

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free GranuFlo lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com

Read the full story at http://www.prweb.com/releases/2013/8/prweb10939356.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Granuflo Multidistrict Litigation Moves Forward: Now, AttorneyOne Can Provide Advice
2. GranuFlo Lawsuit News: W.Va. Man’s Lawsuit Goes to Federal Court, Rottenstein Law Group LLP Reports
3. GranuFlo Lawsuits Move Forward, as Bernstein Liebhard Notes Issuance of New Order in Federal GranuFlo Recall Litigation
4. GranuFlo Lawsuits Moving Forward in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports
5. Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama
6. GranuFlo Lawsuit News: Bernstein Liebhard LLP Reports on Growing Litigation Surrounding GranuFlo Recall
7. New Granuflo Cardiac Arrest Lawsuit: Now, AttorneyOne Can Provide Advice
8. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
9. GranuFlo Lawsuits Filed in Wake of GranuFlo and NaturaLyte Recall Mount in State and Federal Courts, Bernstein Liebhard LLP Reports
10. d'Oliveira & Associates Releases Fresenius Infographic about the FDA Recall of NaturaLyte and GranuFlo
11. GranuFlo Recall Website Launched By Hissey Kientz, LLP Law Firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... June 27, 2017 , ... From June 20-22, EarQ and ... in Syracuse, New York, where EarQ is headquartered. , Together, the organizations educate ... with today’s savvy consumer, and the latest in hearing technology. At the event, ...
(Date:6/27/2017)... ... June 27, 2017 , ... Atmosera , ... Atmosera Managed Azure Services . The trusted, transparent, and secure solution for the ... growing customer base. Atmosera’s next generation services include integrated capabilities for public, private, ...
(Date:6/27/2017)... ... June 27, 2017 , ... A+ Orthodontics is ... specialty that focuses on treating alignment and occlusion irregularities. Treatment often includes the ... , North Hollywood dentist , Dr. Garemani, along with Dr. Reza and ...
(Date:6/26/2017)... ... June 26, 2017 , ... Dr. Martin Bastuba, MD, FACS, ... with the Fertility Center of California, is pleased to announce the addition of ... and TESA (percutaneous testicular sperm extraction). These minimally invasive treatments are primarily used ...
(Date:6/26/2017)... (PRWEB) , ... June 26, 2017 , ... ... coding staff, and consumers are seeing lots of red these days. According to ... inaccurate charges that result from medical coding errors(1). Some studies point to Electronic ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... GAITHERSBURG, Md. , June 7, 2017  Novavax, Inc., ... the second of two Phase 2 trials of its RSV ... women of child bearing age have been published in the ... this publication have been shared in prior scientific conferences). The ... trial in April 2014. Novavax is developing the RSV F ...
(Date:6/2/2017)... 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a leading medical ... new findings demonstrating positive biochemical outcomes related to more ... The data will be presented at the ERA-EDTA Congress ... Spain . The research was ... Network in Europe (KIHDNEy) ...
(Date:5/29/2017)... AVIV, Israel, May 29, 2017  Cellect Biotechnology Ltd. ... innovative technology which enables the functional selection of stem ... results for the first quarter ended March 31 st ... with our accomplishments in the first quarter of 2017," ... first quarter, we announced the treatment of the first ...
Breaking Medicine Technology: